S
Saleh Adi
Researcher at University of California, San Francisco
Publications - 36
Citations - 1665
Saleh Adi is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Type 1 diabetes & Health care. The author has an hindex of 20, co-authored 36 publications receiving 1453 citations.
Papers
More filters
Journal ArticleDOI
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
Jenise C. Wong,Nicole C. Foster,David M. Maahs,Dan Raghinaru,Richard M. Bergenstal,Andrew J. Ahmann,Anne L. Peters,Bruce W. Bode,Grazia Aleppo,Irl B. Hirsch,Lora Kleis,H. Peter Chase,Stephanie N. DuBose,Kellee M. Miller,Roy W. Beck,Saleh Adi +15 more
TL;DR: CGM use is uncommon but associated with lower HbA1c in some age-groups, especially when used more frequently, and factors associated with discontinuation and infrequent use of retrospective analysis of CGM data should be considered in developing next-generation devices and education on CGM use.
Journal ArticleDOI
Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
Mary Ella M Pierpont,Pilar L. Magoulas,Saleh Adi,Maria Ines Kavamura,Giovanni Neri,Jacqueline A. Noonan,Elizabeth I. Pierpont,Kent A. Reinker,Amy E. Roberts,Suma P. Shankar,Joseph Sullivan,Melinda Wolford,Brenda A. Conger,Molly Santa Cruz,Katherine A. Rauen +14 more
TL;DR: Experts in multiple medical specialties provided clinical management guidelines for pediatricians and other care providers that will assist in an accurate diagnosis of individuals with CFC, provide best practice recommendations, and facilitate long-term medical care.
Journal ArticleDOI
Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy
Scott M. Blackman,Dan Raghinaru,Saleh Adi,Jill H. Simmons,Laurie Ebner-Lyon,H. Peter Chase,William V. Tamborlane,Desmond A. Schatz,Jennifer M. Block,Jean C Litton,Vandana Raman,Nicole C. Foster,Craig Kollman,Stephanie N. DuBose,Kellee M. Miller,Roy W. Beck,Linda A. DiMeglio +16 more
TL;DR: Data support the use of insulin pumps in this youngest age group, and suggest that metabolic control may be improved without increasing the frequency of SH, but care should be taken as to the possibly increased risk of DKA.
Journal ArticleDOI
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
Kevan C. Herold,Stephen E. Gitelman,Steven M. Willi,Peter A. Gottlieb,Frank Waldron-Lynch,Lesley Devine,Jennifer L. Sherr,Stephen M. Rosenthal,Saleh Adi,Muhammad Yazid Jalaludin,Aaron W. Michels,James Dziura,Jeffrey A. Bluestone +12 more
TL;DR: This study suggests that deterioration in insulin secretion may be affected by immune therapy with teplizumab after the new-onset period but the magnitude of the effect is less than during the new/onset period.
Journal ArticleDOI
Evidence for Two Classes of Cytokines That Stimulate Hepatic Lipogenesis: Relationships among Tumor Necrosis Factor, Interleukin-1 and Interferon-Alpha*
Carl Grunfeld,Mounzer Soued,Saleh Adi,Arthur H. Moser,Charles A. Dinarello,Kenneth R. Feingold +5 more
TL;DR: Data support the concept that there are two classes of cytokines that stimulate hepatic fatty acid synthesis, those that can increase hepatic citrate levels and those that cannot.